Europe Faces Long Wait for Weight-Loss Drugs
Novo Nordisk will start selling its hugely popular obesity drug Wegovy in Germany this month but only people who pay from their own pocket or have certain private health insurance plans will be able to get it.
Reuters Health Information
source https://www.medscape.com/s/viewarticle/994159?src=rss
Reuters Health Information
source https://www.medscape.com/s/viewarticle/994159?src=rss
Comments
Post a Comment